Israeli biotech firm to test radiation therapy in Fukushima
December 03, 2015 at 05:45 AM EST
JERUSALEM, Dec 3 (Reuters) - Israeli biotech firm Pluristem Therapeutics has partnered with Japan's Fukushima Medical University to test its radiation treatment derived from human placenta cells, which it hopes will protect workers decommissioning nuclear reactors.
